Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionAllstate Corp
Latest Disclosed Ownership127,147 shares
Latest Disclosed Value $ 17,720,478
Allstate Corp reports 36.57% increase in ownership of GILD / Gilead Sciences, Inc.

On May 11, 2026 - Allstate Corp filed a 13F-HR form disclosing ownership of 127,147 shares of Gilead Sciences, Inc. (CH:GILD) valued at $17,720,478 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 93,103 shares of Gilead Sciences, Inc.. This represents a change in shares of 36.57% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F GILEAD SCIENCES ORD Equity 375558103 127,147 34,044 36.57 17,720 55.07 0.1753
2026-02-09 2025-12-31 13F GILEAD SCIENCES ORD Equity 375558103 93,103 47,838 105.68 11,427 127.45 0.1561
2025-10-29 2025-09-30 13F GILEAD SCIENCES ORD Equity 375558103 45,265 42,683 1,653.10 5,024 1,656.64 0.1147
2025-08-05 2025-06-30 13F GILEAD SCIENCES ORD Equity 375558103 2,582 -41,452 -94.14 286 -94.20 0.0206
2025-05-14 2025-03-31 13F GILEAD SCIENCES ORD Equity 375558103 44,034 6,986 18.86 4,934 44.18 0.1450
2025-02-12 2024-12-31 13F GILEAD SCIENCES ORD Equity 375558103 37,048 37,048 3,422 0.1008
2024-11-14 2024-09-30 13F GILEAD SCIENCES EQU 375558103 0 -3,656 -100.00 0 -100.00
2024-08-13 2024-06-30 13F GILEAD SCIENCES EQU 375558103 3,656 -593 -13.96 251 -19.61 0.0204
2024-05-10 2024-03-31 13F GILEAD SCIENCES EQU 375558103 4,249 187 4.60 311 -5.47 0.0221
2024-02-09 2023-12-31 13F GILEAD SCIENCES EQU 375558103 4,062 183 4.72 329 13.45 0.0227
2023-11-13 2023-09-30 13F GILEAD SCIENCES EQU 375558103 3,879 0 0.00 291 -2.68 0.0170
2023-08-14 2023-06-30 13F GILEAD SCIENCES EQU 375558103 3,879 0 0.00 299 -7.17 0.0190
2023-05-10 2023-03-31 13F GILEAD SCIENCES EQU 375558103 3,879 -42,667 -91.67 322 -91.96 0.0239
2023-02-14 2022-12-31 13F GILEAD SCIENCES EQU 375558103 46,546 748 1.63 3,996 41.42 0.1215
2022-11-14 2022-09-30 13F GILEAD SCIENCES EQU 375558103 45,798 -885 -1.90 2,825 -2.08 0.0813
2022-08-15 2022-06-30 13F GILEAD SCIENCES EQU 375558103 46,683 27,842 147.77 2,885 157.59 0.0888
2022-05-16 2022-03-31 13F GILEAD SCIENCES EQU 375558103 18,841 -73,249 -79.54 1,120 -83.25 0.0299
2022-02-15 2021-12-31 13F GILEAD SCIENCES EQU 375558103 92,090 79,008 603.94 6,687 631.62 0.1277
2021-11-15 2021-09-30 13F GILEAD SCIENCES EQU 375558103 13,082 -2,783 -17.54 914 -16.30 0.0378
2021-08-16 2021-06-30 13F GILEAD SCIENCES EQU 375558103 15,865 -2,472 -13.48 1,092 -7.85 0.0366
2021-05-14 2021-03-31 13F GILEAD SCIENCES EQU 375558103 18,337 9,723 112.87 1,185 136.06 0.0372
2021-02-12 2020-12-31 13F GILEAD SCIENCES EQU 375558103 8,614 -7,749 -47.36 502 -51.45 0.0156
2020-11-13 2020-09-30 13F GILEAD SCIENCES EQU 375558103 16,363 -19,753 -54.69 1,034 -62.79 0.0336
2020-08-13 2020-06-30 13F GILEAD SCIENCES EQU 375558103 36,116 2,967 8.95 2,779 12.15 0.0955
2020-05-15 2020-03-31 13F GILEAD SCIENCES COMMON 375558103 33,149 20,493 161.92 2,478 201.46 0.0971
2020-02-14 2019-12-31 13F GILEAD SCIENCES COMMON 375558103 12,656 12,656 822 0.0149
2019-11-14 2019-09-30 13F GILEAD SCIENCES COMMON 375558103 0 -33,225 -100.00 0 -100.00
2019-08-14 2019-06-30 13F GILEAD SCIENCES COMMON 375558103 33,225 -22,035 -39.88 2,245 -37.50 0.0401
2019-05-20 2019-03-31 13F GILEAD SCIENCES COMMON 375558103 55,260 30,873 126.60 3,592 135.54 0.0968
2019-02-13 2018-12-31 13F GILEAD SCIENCES COMMON 375558103 24,387 24,387 1,525 0.0501
2017-11-14 2017-09-30 13F GILEAD SCIENCES COMMON 375558103 0 -31,444 -100.00 0 -100.00
2017-08-14 2017-06-30 13F GILEAD SCIENCES COMMON 375558103 31,444 31,444 2,226 0.1183
2017-05-15 2017-03-31 13F GILEAD SCIENCES COMMON 375558103 0 -76,442 -100.00 0 -100.00
2017-02-14 2016-12-31 13F GILEAD SCIENCES COMMON 375558103 76,442 71,950 1,601.74 5,474 1,441.97 0.3273
2016-11-14 2016-09-30 13F GILEAD SCIENCES COMMON 375558103 4,492 -5,257 -53.92 355 -56.33 0.0250
2016-08-11 2016-06-30 13F GILEAD SCIENCES COMMON 375558103 9,749 -6,537 -40.14 813 -45.66 0.0532
2016-05-16 2016-03-31 13F GILEAD SCIENCES COMMON 375558103 16,286 -26,678 -62.09 1,496 -65.59 0.1290
2016-02-16 2015-12-31 13F GILEAD SCIENCES COMMON 375558103 42,964 42,964 0.00 4,348 0.4138
2014-11-14 2014-09-30 13F GILEAD SCIENCES COMMON 375558103 0 -126,500 -100.00 0 -100.00
2014-08-14 2014-06-30 13F GILEAD SCIENCES COMMON 375558103 126,500 -68,979 -35.29 10,488 -24.29 0.2836
2014-05-15 2014-03-31 13F GILEAD SCIENCES COMMON 375558103 195,479 195,479 13,852 0.4462
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.